St. John's Hospital, founded in 1875 by the Hospital Sisters of St. Francis, has 457 licensed beds and is a primary teaching hospital for the Southern Illinois University School of Medicine.

There are 457 beds in St. John's Hospital.

During the past decade, St. John's Hospital conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 21 clinical trials were completed, i.e. on average, 84% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 11 clinical trials were completed. i.e. 157.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. John's Hospital" #1 sponsor was "Boston Scientific Corporation" with 18 trials, followed by "National Cancer Institute (NCI)" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 6 trials sponsored, "Abbott Medical Devices" with 5 trials sponsored and "Children's Oncology Group" with 5 trials sponsored. Other sponsors include 17 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. John's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 12 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Radiation Therapy Oncology Group" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "St. John's Hospital" are "Coronary Artery Disease" (16 trials), "Coronary Artery Stenosis" (4 trials), "Coronary Disease" (4 trials), "Atrial Fibrillation" (3 trials) and "Heart Failure" (3 trials). Many other conditions were trialed in "St. John's Hospital" in a lesser frequency.

Most popular intervention types in "St. John's Hospital" are "Device" (31 trials), "Drug" (27 trials), "Radiation" (11 trials), "Other" (9 trials) and "Procedure" (8 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (4 trials), "Vincristine Sulfate" (4 trials), "Doxorubicin Hydrochloride" (3 trials), "Etoposide" (3 trials) and "Ifosfamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "St. John's Hospital" are 55 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "St. John's Hospital". undefined are not yet recruiting, 4 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 35 completed trials in St. John's Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in St. John's Hospital, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 32 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 18 trials that are defined as “Not Applicable".

St. John's Hospital has several departments that took part in Clinical trials: "Saint Vincent Hospital Cancer Center at Oconto Falls" - 127 trials, "HSHS Sacred Heart Hospital" - 103 trials, "Saint Vincent Hospital Cancer Center Green Bay" - 509 trials, "Saint Vincent Hospital Cancer Center at Saint Mary's" - 179 trials, "Cancer Institute at St. John's Hospital" - 28 trials, "Center for Cancer Treatment & Prevention at Sacred Heart Hospital" - 24 trials, "St. John's Hospital, Prairie Education and Research Cooperative" - 4 trials, "HSHS Medical Group Diabetes Research" - 3 trials, "Prairie Heart - St. John's Hospital" - 2 trials